PSNL News

Slack's (WORK) widely-covered direct listing was hailed as a success. Slack opened on Thursday at $38.50, well above the NYSE's "reference price" of $26, and more than triple its last round less than a year ago. And yet, new public investors ended the week with losses. The stock closed Friday at $37.22, down 3.3% from the opening trade. With millions of users...read more

Personalis, which provides a genome sequencing platform for cancer drug development, raised $135 million by offering 7.9 million shares at $17, above the range of $14 to $16. The company originally filed to offer 6.7 million shares. Personalis plans to list on the Nasdaq under the symbol PSNL. Morgan Stanley, BofA Merrill Lynch and Cowen acted as joint book-running...read more

A wave of biotechs are preparing to go public in June, with five on the IPO calendar for this week and four more scheduled for the week of June 24. Two others could soon launch June/July IPOs as well. Recent biotech IPOs have mostly underperformed, though 2 are up +100% ...read more

Eight companies are going public in the week ahead, including five biotechs, a genome sequencer, a discount grocer, and a the popular workplace messaging software Slack (WORK). Slack will be the second-ever major direct listing, following Spotify (SPOT) last year, and provide an important data point on its viability as an alternative to IPOs in certain...read more